Consultants

Infectious Disease Specialist

Dr. Kalamalini Wijeyasangary is a highly distinguished Infectious Disease specialist with over 25 years of clinical expertise. She is widely recognized for her contributions to public health and her skill in managing complex, life-threatening infections.

Her career is defined by a rigorous academic foundation and specialized training from some of the world's most prestigious institutions.

Specialized Training

Dr. Wijeyasangary's expertise is built upon a global training pedigree:

1. CMC Vellore:She completed her foundational medical studies and advanced training at the Christian Medical College (CMC), Vellore, one of India's premier medical institutions known for excellence in infectious disease research.
2. YRG CARE: She underwent specialized training at YRG CARE (Chennai), a pioneer center for HIV/AIDS care and research in India.
3. Miriam Hospital, USA: She furthered her international exposure and clinical skills by training at The Miriam Hospital (affiliated with Brown University) in the United States, focusing on cutting-edge treatments for viral diseases.

Clinical Expertise

With a quarter-century of experience, Dr. Wijeyasangary specializes in treating complicated and drug-resistant cases. Her primary areas of focus include:

1. HIV/AIDS: Management of opportunistic infections and long-term Antiretroviral Therapy (ART).
2. Tuberculosis (TB): Specialized care for Pulmonary, Extra-pulmonary, and Multi-Drug Resistant TB (MDR-TB).
3. Viral Hepatitis: Comprehensive treatment for Hepatitis B and Hepatitis C, including modern antiviral protocols.
4. General Infectious Diseases: Diagnosis and management of common infections, tropical diseases, and unexplained fevers.

Awards and National Impact

Dr. Wijeyasangary has been a pivotal figure in India's fight against HIV. One of her most significant achievements is receiving a National Award for her success in PMTCT (Prevention of Mother-to-Child Transmission).

Her work in this field has been instrumental in ensuring that infants born to HIV-positive mothers remain HIV-free, a cornerstone of public health success in infectious disease management.

Research & Publications: Dr. Kalamalini Wijeyasangary

Dr. Kalamalini Wijeyasangary has been a dedicated voice in the global effort to manage and prevent HIV/AIDS. Her work, particularly presented at the XVI International AIDS Conference (2006) and other prestigious international forums, focuses on the practical challenges and solutions within resource-poor clinical settings.

Key Contributions & Presentations

Immune Reconstitution Inflammatory Syndrome (IRIS)

• > Presented at the XVI International AIDS Conference, 2006
• > Dr. Wijeyasangary's research highlighted the clinical observations of Immune
• > Reconstitution Syndrome among patients in South India. This work provided critical insights into how the immune system reacts when beginning treatment in environments where medical resources are scarce, helping clinicians better manage the paradoxical worsening of infections during recovery.

Opportunistic Infections in ART-Naïve Patients

• > Presented at the XVI International AIDS Conference, 2006
• > Focusing on patients who had not yet begun Antiretroviral Therapy (ART), this study documented the prevalence and patterns of opportunistic infections in South India. By identifying the specific vulnerabilities of this demographic, the research underscored the urgent need for early intervention and diagnostic support in rural or underfunded clinics.

HIV Prevention: The Female Condom

• > Presented at International Conferences, Thailand
• > Beyond clinical treatment, Dr. Wijeyasangary has been a proponent of empowering prevention methods. Her work presented in Thailand explored the efficacy and implementation of the female condom as a vital tool for HIV prevention. This research emphasizes reproductive health autonomy and the necessity of providing diverse prevention options to women globally.

Impact and Advocacy

Impact and AdvocacyDr. Wijeyasangary's work bridges the gap between high-level clinical research and the ground-level reality of healthcare in South Asia. By presenting these findings on the international stage, she has contributed to a more nuanced global understanding of the HIV epidemic in developing regions.